Israel Health News API

{
    "totalArticles": 18448,
    "articles": [
        {
            "id": "1e266bf68bb93ae5193ed17a6ce1a6ab",
            "title": "Gastroenterologist: Antibiotics wreck the gut and probiotics will not help",
            "description": "A gastroenterologist explains why probiotic supplements do not always help and what is recommended to do instead to minimize damage.",
            "content": "Many of us are familiar with the situation: The doctor prescribes antibiotics for strep throat, sinusitis, or another infection, and within minutes, the recommendation from friends or family members arrives: \"Don't forget to take probiotics to protec... [4998 chars]",
            "url": "https://www.jpost.com/health-and-wellness/health-and-wellness-around-the-world/article-898653",
            "image": "https://images.jpost.com/image/upload/f_auto,fl_lossy/q_auto/c_fill,g_faces:center,h_720,w_1280/724683",
            "publishedAt": "2026-06-18T14:00:00Z",
            "lang": "en",
            "source": {
                "id": "78834c45a26f98bca295cc641123cf7f",
                "name": "The Jerusalem Post",
                "url": "https://www.jpost.com"
            }
        },
        {
            "id": "42bb886c45d2d82787ec7c96d0c97b8e",
            "title": "Placental abruption could increase risk of cardiovascular disease in women",
            "description": "A published study found that placental abruption was associated with an increased risk of non-fatal cardiovascular disease hospitalisation.",
            "content": "Cardiovascular disease (CVD) is the leading cause of death globally, with the World Health Organization (WHO) estimating that 19.8 million people died from CVDs in 2022. CVDs encompass a wide range of conditions, including coronary heart disease, ath... [3369 chars]",
            "url": "https://www.clinicaltrialsarena.com/analyst-comment/placental-abruption-cardiovascular-disease/",
            "image": "https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2026/06/shutterstock_2264910837.jpg",
            "publishedAt": "2026-06-18T13:52:00Z",
            "lang": "en",
            "source": {
                "id": "5fc6401b64c5c4ee117332a7a598b722",
                "name": "Clinical Trials Arena",
                "url": "https://www.clinicaltrialsarena.com"
            }
        },
        {
            "id": "b5083a29dd53a69e04e2a82ea9e17d2b",
            "title": "Long-term Data Show Continued Efficacy and Safety of Sparsentan in FSGS",
            "description": "Long-term open-label extension data from the phase 3 DUPLEX trial of sparsentan showed lasting proteinuria reduction in focal segmental glomerulosclerosis (FSGS).",
            "content": "Patients with focal segmental glomerulosclerosis (FSGS) are at increased risk of progression to kidney failure within 10 years of diagnosis. Studies have shown an association between lowering proteinuria across a range of thresholds and a reduction i... [1577 chars]",
            "url": "https://www.docwirenews.com/post/long-term-data-show-continued-efficacy-and-safety-of-sparsentan-in-fsgs",
            "image": "https://mumcdnstorage.blob.core.windows.net/dwnews/2025/01/iStock-2150133519.jpg",
            "publishedAt": "2026-06-18T13:50:41Z",
            "lang": "en",
            "source": {
                "id": "885ae2dda50884da7e0cf7fb8d4aa961",
                "name": "Docwire News",
                "url": "https://www.docwirenews.com"
            }
        }
    ]
}